Tevogen Bio Holdings Inc.

NASDAQ (USD): Tevogen Bio Holdings Inc. (TVGN)

Last Price

1.05

Today's Change

-0.08 (7.07%)

Day's Change

1.01 - 1.13

Trading Volume

1,855,464

Profile
TVGN

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Ryan H. Saadi M.D., M.P.H, M.P.H. Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.

Full Time Employees:  17 17

IPO Date:  2022-01-05 2022-01-05

CIK:  0001860871 0001860871

ISIN:  US88165K1016 US88165K1016

CUSIP: 

Beta:  -1.03 -1.03

Last Dividend:  0.00 0.00

Dcf Diff:  1.08 1.08

Dcf:  -0.01 -0.01

Description

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Address

15 Independence Blvd,
Warren, NJ 07059, US

877 838 6436

http://tevogen.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment